Digoxin 0.1875 MG Oral Tablet — RxCUI 1441565
RxNorm drug concept · Semantic clinical drug
RxCUI 1441565
Semantic clinical drug · SCD
Retired or remapped concept 3 FDA products
4 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1441565
Official nameDigoxin 0.1875 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusRetired or remapped concept
FDA products mapped3
Package NDCs mapped4
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Digoxin: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Digoxin is being used for one of two main reasons: either to help your heart pump more effectively in heart failure, or to slow down a fast heart rate caused by atrial fibrillation...
- Why did my doctor prescribe digoxin — what is it actually doing for me?
- The most important ones to call your doctor about are nausea, vomiting, loss of appetite, unusual vision changes (like seeing a yellow-green tint or halos around lights), dizziness...
- What side effects should I actually watch out for?
🕸️ Concept Web
No related-concept groups were available for this RxCUI in the loaded RxNorm data. That does not prove that no related concepts exist.
📦 FDA Products & Package NDCs
3 products · 4 package NDCs
4 package NDCs map to RxCUI 1441565 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 59212-0240-55 | 100 TABLET in 1 BOTTLE (59212-240-55) | LANOXIN | Advanz Pharma (US) Corp. | 2012-09-30 |
| 59212-0242-55 | 100 TABLET in 1 BOTTLE (59212-242-55) | LANOXIN | Advanz Pharma (US) Corp. | 2012-09-30 |
| 59212-0242-56 | 10 BLISTER PACK in 1 CARTON (59212-242-56) / 10 TABLET in 1... | LANOXIN | Advanz Pharma (US) Corp. | 2012-09-30 |
| 59212-0249-55 | 100 TABLET in 1 BOTTLE (59212-249-55) | LANOXIN | Advanz Pharma (US) Corp. | 2012-09-30 |
Observed labelers:
Advanz Pharma (US) Corp. (4)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.